Focused Investors LLC Increases Position in Johnson & Johnson (JNJ)

September 16, 2018 - By Julie Barnes

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.97 in Q2 2018. Its up 0.04, from 0.93 in 2018Q1. It increased, as 36 investors sold JNJ shares while 806 reduced holdings. 114 funds opened positions while 704 raised stakes. 1.84 billion shares or 8.07% more from 1.71 billion shares in 2018Q1 were reported. Swift Run Cap Mgmt stated it has 0.24% of its portfolio in Johnson & Johnson (NYSE:JNJ). Neumann Management Limited Liability Company owns 1.04% invested in Johnson & Johnson (NYSE:JNJ) for 13,630 shares. Grassi Invest Mgmt invested 1.19% in Johnson & Johnson (NYSE:JNJ). Baker Ellis Asset Ltd Liability has invested 1.01% in Johnson & Johnson (NYSE:JNJ). Lincoln Capital Ltd Liability Company owns 32,034 shares. Bragg Fincl has invested 1.09% in Johnson & Johnson (NYSE:JNJ). Wellington Mngmt Limited Liability Partnership invested in 0.65% or 23.89M shares. Dorsey & Whitney Tru Co Ltd Liability Com accumulated 2.27% or 107,809 shares. State Of Tennessee Treasury Department accumulated 1.32M shares or 0.81% of the stock. Blair William Il reported 719,159 shares. The Pennsylvania-based Ajo LP has invested 2.5% in Johnson & Johnson (NYSE:JNJ). Moreover, Willow Creek Wealth Management has 0.33% invested in Johnson & Johnson (NYSE:JNJ). Ing Groep Nv owns 549,961 shares. Macroview Investment Mgmt Ltd Liability Corp stated it has 417 shares or 0.18% of all its holdings. Jacobs Ca owns 58,056 shares.

Since August 27, 2018, it had 0 insider purchases, and 2 insider sales for $4.99 million activity. Sneed Michael E sold $3.91 million worth of Johnson & Johnson (NYSE:JNJ) on Monday, August 27.

Focused Investors Llc increased its stake in Johnson & Johnson (JNJ) by 6.09% based on its latest 2018Q2 regulatory filing with the SEC. Focused Investors Llc bought 69,200 shares as the company’s stock rose 13.64% with the market. The institutional investor held 1.21M shares of the major pharmaceuticals company at the end of 2018Q2, valued at $146.37M, up from 1.14M at the end of the previous reported quarter. Focused Investors Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $374.22 billion market cap company. The stock decreased 0.29% or $0.4 during the last trading session, reaching $139.49. About 4.53 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 5.07% since September 16, 2017 and is uptrending. It has underperformed by 10.55% the S&P500.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “J&J working on India hip compensation” on September 07, 2018, also Seekingalpha.com with their article: “Dividend Champion Spotlight: Johnson & Johnson” published on September 02, 2018, Seekingalpha.com published: “Johnson & Johnson (JNJ) CEO Alex Gorsky Presents at 2018 Wells Fargo 13th Annual Healthcare Conference …” on September 06, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Breakout Alert: Buy Johnson & Johnson” published on August 20, 2018 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson (JNJ) Management Presents at Barclays Global Consumer Staples Conference Call (Transcript)” with publication date: September 06, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 9 analysts covering Johnson & Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Johnson & Johnson had 13 analyst reports since March 23, 2018 according to SRatingsIntel. The rating was maintained by Wells Fargo on Wednesday, April 18 with “Buy”. Leerink Swann maintained the stock with “Buy” rating in Thursday, May 17 report. Goldman Sachs upgraded Johnson & Johnson (NYSE:JNJ) on Thursday, July 12 to “Neutral” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Jefferies on Friday, April 13. The rating was maintained by Stifel Nicolaus with “Hold” on Wednesday, April 18. Deutsche Bank maintained the shares of JNJ in report on Wednesday, April 18 with “Buy” rating. Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with “Buy” rating. The firm earned “Outperform” rating on Friday, April 20 by Credit Suisse. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Friday, March 23 by Jefferies. As per Tuesday, April 10, the company rating was maintained by Morgan Stanley.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.